{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,2]],"date-time":"2026-03-02T12:03:03Z","timestamp":1772452983450,"version":"3.50.1"},"reference-count":18,"publisher":"MDPI AG","issue":"2","license":[{"start":{"date-parts":[[2026,2,28]],"date-time":"2026-02-28T00:00:00Z","timestamp":1772236800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Hematology Reports"],"abstract":"<jats:p>Background: Nodular lymphocyte-predominant Hodgkin lymphoma (NLPHL) is an indolent B-cell lymphoma with long-term survival and a tendency for late relapse. Hepatic manifestations of varying etiologies have been described in lymphoproliferative disorders. However, paraneoplastic hepatitis is rare, and reports typically describe acute presentations. We describe an unusual case of paraneoplastic hepatitis with an indolent and progressive clinical course occurring in the setting of relapsed NLPHL. Case Presentation: A 32-year-old man with a history of NLPHL was found to have marked transaminase elevation with preserved liver function during routine follow-up. Extensive evaluation excluded viral, autoimmune, and metabolic causes of liver disease. Liver biopsy demonstrated confluent and bridging necrosis with lymphoplasmacytic infiltrates, without evidence of direct lymphoma involvement. Excisional biopsy of a cervical lymph node revealed relapse of NLPHL without histologic transformation. Treatment with corticosteroids resulted in partial biochemical improvement, and subsequent rituximab monotherapy achieved lymphoma remission. Despite this, low-grade transaminase elevation persisted, and follow-up imaging and liver biopsy demonstrated progression to fibrosis, suggesting a tendency towards chronicity. Conclusions: Paraneoplastic hepatitis should be considered in patients with NLPHL who present with unexplained liver abnormalities. This report illustrates a fibrosing form of paraneoplastic hepatitis associated with NLPHL and broadens the clinical spectrum of paraneoplastic hepatic injury. Early recognition, histological confirmation, and tailored immunosuppressive management are critical to optimizing hepatic and lymphoma-related outcomes.<\/jats:p>","DOI":"10.3390\/hematolrep18020018","type":"journal-article","created":{"date-parts":[[2026,3,2]],"date-time":"2026-03-02T10:24:34Z","timestamp":1772447074000},"page":"18","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Paraneoplastic Hepatitis Associated with Relapsed Nodular Lymphocyte-Predominant Hodgkin Lymphoma"],"prefix":"10.3390","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2911-6712","authenticated-orcid":false,"given":"Jasmin","family":"Nelissen","sequence":"first","affiliation":[{"name":"Department of Hematology, Erasmus Medical Center, 3015 GD Rotterdam, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sandra","family":"Coenen","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Erasmus Medical Center, 3015 GD Rotterdam, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3903-1085","authenticated-orcid":false,"given":"King","family":"Lam","sequence":"additional","affiliation":[{"name":"Department of Pathology, Erasmus Medical Center, 3015 GD Rotterdam, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8611-840X","authenticated-orcid":false,"given":"Michael","family":"Doukas","sequence":"additional","affiliation":[{"name":"Department of Pathology, Erasmus Medical Center, 3015 GD Rotterdam, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Harry L. A.","family":"Janssen","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Erasmus Medical Center, 3015 GD Rotterdam, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8751-5725","authenticated-orcid":false,"given":"Yasmina","family":"Serroukh","sequence":"additional","affiliation":[{"name":"Department of Hematology, Erasmus Medical Center, 3015 GD Rotterdam, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2026,2,28]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"2987","DOI":"10.1182\/blood.2019004044","article-title":"How I treat nodular lymphocyte-predominant Hodgkin lymphoma","volume":"136","author":"Eichenauer","year":"2020","journal-title":"Blood"},{"key":"ref_2","first-page":"3476","article-title":"Nodular lymphocyte-predominant Hodgkin lymphoma: Advances in disease biology, risk stratification, and treatment","volume":"109","author":"Salvaris","year":"2024","journal-title":"Haematologica"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.cld.2018.12.010","article-title":"Hepatic Manifestations of Lymphoproliferative Disorders","volume":"23","author":"Bunchorntavakul","year":"2019","journal-title":"Clin. Liver Dis."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"366","DOI":"10.3748\/wjg.v23.i2.366","article-title":"Vanishing bile duct syndrome in Hodgkin\u2019s lymphoma: A case report and literature review","volume":"23","author":"Bakhit","year":"2017","journal-title":"World J. Gastroenterol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"77","DOI":"10.3816\/CLM.2006.n.044","article-title":"Idiopathic cholestasis as a paraneoplastic phenomenon in Hodgkin\u2019s lymphoma","volume":"7","author":"Barta","year":"2006","journal-title":"Clin. Lymphoma Myeloma"},{"key":"ref_6","first-page":"189","article-title":"Hodgkin\u2019s disease presenting with fulminant liver disease","volume":"15","author":"Gunasekaran","year":"1992","journal-title":"J. Pediatr. Gastroenterol. Nutr."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1097\/00042737-199909000-00019","article-title":"Fulminant hepatic failure as a presenting paraneoplastic manifestation of Hodgkin\u2019s disease","volume":"11","author":"Dourakis","year":"1999","journal-title":"Eur. J. Gastroenterol. Hepatol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1186\/s13256-023-04014-9","article-title":"Relapsed nodular lymphocyte-predominant Hodgkin lymphoma presenting as severe paraneoplastic hepatitis: A case report","volume":"17","author":"Deacon","year":"2023","journal-title":"J. Med. Case Rep."},{"key":"ref_9","first-page":"567289","article-title":"Autoimmune hemolytic anemia and nodular lymphocyte-predominant hodgkin lymphoma: A rare association","volume":"2013","author":"Salmeron","year":"2013","journal-title":"Case Rep. Hematol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"2009","DOI":"10.1080\/10428190802276289","article-title":"Paraneoplastic lumbosacral axonal polyradiculopathy preceding the diagnosis of nodular lymphocyte predominant Hodgkin lymphoma: A case report","volume":"49","author":"Ingber","year":"2008","journal-title":"Leuk. Lymphoma"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/j.pathol.2022.08.012","article-title":"Paraneoplastic primary CNS angiitis secondary to nodular lymphocyte predominant Hodgkin lymphoma","volume":"55","author":"Li","year":"2023","journal-title":"Pathology"},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Inui, R., Saito, K., Shimomura, Y., Yamashita, D., Kawamoto, M., and Ishikawa, T. (2020). Anti-Ma-associated paraneoplastic cerebellar degeneration in a patient with nodular lymphocyte-predominant Hodgkin lymphoma: A case report. BMC Neurol., 20.","DOI":"10.1186\/s12883-020-01929-4"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1007\/s00277-023-05357-5","article-title":"Paraneoplastic syndromes associated with classic Hodgkin lymphoma, a systematic literature review","volume":"103","author":"Bajuaifer","year":"2024","journal-title":"Ann. Hematol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.1016\/S0140-6736(20)32207-8","article-title":"Classical Hodgkin lymphoma","volume":"398","author":"Brice","year":"2021","journal-title":"Lancet"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"838","DOI":"10.4065\/mcp.2010.0099","article-title":"Paraneoplastic syndromes: An approach to diagnosis and treatment","volume":"85","author":"Pelosof","year":"2010","journal-title":"Mayo Clin. Proc."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1111\/bjh.18376","article-title":"Tumour cell characteristics and microenvironment composition correspond to clinical presentation in newly diagnosed nodular lymphocyte-predominant Hodgkin lymphoma","volume":"199","author":"Hartmann","year":"2022","journal-title":"Br. J. Haematol."},{"key":"ref_17","first-page":"312817","article-title":"Autoimmune hepatitis as a unique form of an autoimmune liver disease: Immunological aspects and clinical overview","volume":"2012","author":"Fallatah","year":"2012","journal-title":"Autoimmune Dis."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/S0168-8278(00)00095-7","article-title":"Duration of immunosuppressive therapy in autoimmune hepatitis","volume":"34","author":"Kanzler","year":"2001","journal-title":"J. Hepatol."}],"container-title":["Hematology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2038-8330\/18\/2\/18\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,2]],"date-time":"2026-03-02T11:12:04Z","timestamp":1772449924000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2038-8330\/18\/2\/18"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,28]]},"references-count":18,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2026,4]]}},"alternative-id":["hematolrep18020018"],"URL":"https:\/\/doi.org\/10.3390\/hematolrep18020018","relation":{},"ISSN":["2038-8330"],"issn-type":[{"value":"2038-8330","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,28]]}}}